These mutual funds consistently outperform general equity schemes – Should you invest?

An examination of 25 multi-asset funds has shown they have surpassed the performance of most general equity schemes over one, three, and five-year periods. These funds are distinguished by their ability to generate competitive returns across various asset classes, offering a diversified investment strategy that is often absent in single-asset equity funds, as per a report from Ventura Securities.

The growing appeal of Multi Asset Allocation Funds can be attributed to their capacity for diversification, potential tax advantages, and superior risk-adjusted returns.

“Certain Multi Asset Allocation Funds have outperformed the majority of equity schemes, highlighting the advantages these funds can offer. The analysis conducted by Ventura Securities emphasizes the significant benefits of multi-asset funds, including strong returns. These funds present appealing choices for investors aiming for a balanced risk-reward profile. Nevertheless, the differences in performance highlight the necessity of choosing funds that align with individual investment goals and risk tolerance, reinforcing the idea that a uniform approach is not suitable for all in multi-asset allocation,” says Juzer Gabajiwala, Director at Ventura Securities Ltd.

Also Read: NPS Calculator: How much to save in NPS today for a Rs 1.5 lakh monthly pension post retirement?

Performance of select Multi Asset Allocation Funds and the percentage of equity schemes, each has outperformed

The Multi Asset Fund from Quant AMC has shown a notable performance, outperforming approximately 79% of equity schemes based on its 3-year returns and 86% over a 5-year period. Its allocation strategy, despite a controlled equity exposure of less than 51%, has proven successful in surpassing the returns of numerous equity funds. ICICI Prudential Multi Asset excelled, outperforming 63% of equity schemes’ returns over a 3-year period and nearly 50% over a 5-year timeframe.

No. of Equity Schemes [1 Year: 640, 3 Years: 458 & 5 Years: 366]

Asset Allocation strategies across all 25 Multi Asset Allocation Funds

The allocation strategies that exist across 25 multi-asset allocation funds show a huge variation, heavy on equity and debt along with a mix of gold and silver, arbitrage and other alternative assets. This diversity underscores the fact that ‘one size does not fit all’ as each fund follows a distinct strategy tailored to different market conditions and investor objectives.

Some funds have outperformed large-cap funds by delivering higher returns with lower associated risk.

 » Read More

Related Articles

8th Pay Commission: Central govt to merge pay scales for Level 1-6 employees? Here’s what the new proposal says

8th Pay Commission: The National Council of Joint Consultative Machinery (JCM) Staff Side has submitted its recommendations for the Terms of Reference (ToR) for the 8th Central Pay Commission (CPC), advocating significant changes in pay structure, allowances and benefits for government employees. Among the key points of ToR is the proposal for merger of certain

Bharti Airtel Q3 Results: Profit surges 505.24% to Rs 14,781.20 crore, ARPU at Rs 245

Bharti Airtel on Thursday posted a profit of Rs 14,781.20 crore during the third quarter of FY25, reporting a growth of 505.24 per cent in comparison to Rs 2442.20 crore during the corresponding quarter of FY24. The telecom major recorded Q3 revenue from operations at Rs 45,129.30 crore, up 19.08 per cent as against Rs

JB Pharma is riding the CDMO Opportunity. Jefferies reiterates buy…

Jefferies has maintained a Buy on JB Pharma with a revised target price of Rs 2,310. The stock currently trades at Rs 1,714/share implying an 34% upside. This new target price is just a shade lower than the previous target price of Rs 2,340. According to Jefferies, an international brokerage house, the growth drivers are

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

8th Pay Commission: Central govt to merge pay scales for Level 1-6 employees? Here’s what the new proposal says

8th Pay Commission: The National Council of Joint Consultative Machinery (JCM) Staff Side has submitted its recommendations for the Terms of Reference (ToR) for the 8th Central Pay Commission (CPC), advocating significant changes in pay structure, allowances and benefits for government employees. Among the key points of ToR is the proposal for merger of certain

Bharti Airtel Q3 Results: Profit surges 505.24% to Rs 14,781.20 crore, ARPU at Rs 245

Bharti Airtel on Thursday posted a profit of Rs 14,781.20 crore during the third quarter of FY25, reporting a growth of 505.24 per cent in comparison to Rs 2442.20 crore during the corresponding quarter of FY24. The telecom major recorded Q3 revenue from operations at Rs 45,129.30 crore, up 19.08 per cent as against Rs

JB Pharma is riding the CDMO Opportunity. Jefferies reiterates buy…

Jefferies has maintained a Buy on JB Pharma with a revised target price of Rs 2,310. The stock currently trades at Rs 1,714/share implying an 34% upside. This new target price is just a shade lower than the previous target price of Rs 2,340. According to Jefferies, an international brokerage house, the growth drivers are

Two banking stocks to watch ahead of the RBI Policy

By Kiran Jani Bank Nifty reached its all-time high of 54,467 in September 2024. Following this peak, the index experienced a correction, dipping to 47,844 in January 2025—a decline of 7.29%. Despite this pullback, Kotak Bank and ICICI Bank showed relative resilience, delivering returns of 1.61% and -4.20%, respectively, during the same period. Source: Investing.com

New Tax Regime: These deductions, exemptions still available for you

The Indian government introduced a new tax regime in 2020, offering lower tax rates while removing several exemptions and deductions available under the old system. Initially optional, this regime became the default in 2023, requiring taxpayers to opt out if they wished to continue under the old structure. Despite the removal of many benefits, certain